Related Experiment Video
Updated: Apr 12, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
[A Case of Paradoxical Reaction Development during Antituberculosis Therapy]
Young Bum Cho1, Min Su Chu1, Han Seung Ryu1
1Department of Internal Medicine, Digestive Disease Research Institute, Wonkwang University School of Medicine, Iksan, Korea.
A paradoxical reaction, an immune response worsening tuberculosis, occurred in a patient treated for abdominal and pulmonary tuberculosis. Corticosteroid therapy alongside antituberculosis agents led to complete recovery.
Area of Science:
- Immunology
- Infectious Diseases
- Pulmonology
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- Antituberculosis therapy (ATT) can sometimes trigger paradoxical reactions.
- Paradoxical reactions manifest as worsening or new tuberculous lesions despite treatment.
Observation:
- A 24-year-old female with abdominal and pulmonary TB experienced fever and abdominal pain after 4 months of ATT.
- Abdominal CT revealed tuberculous mesenteric lymphadenitis and an enlarged necrotic abscess.
- Symptoms persisted despite surgical intervention (adhesiolysis and abscess drainage).
Findings:
- The patient's condition was attributed to a paradoxical reaction, not treatment failure.
- Combined corticosteroid and ATT administration resulted in complete recovery.
- This case highlights the importance of recognizing paradoxical reactions in TB management.
Implications:
- Corticosteroids may be a crucial adjunct therapy for managing paradoxical reactions in TB.
- Early recognition and appropriate management of paradoxical reactions can improve patient outcomes.
- Further research into the mechanisms and optimal treatment of paradoxical reactions is warranted.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Drug toxicity: Idiosyncratic Reactions